130 related articles for article (PubMed ID: 8386185)
1. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.
Basile JN; Liel Y; Shary J; Bell NH
J Clin Invest; 1993 Apr; 91(4):1396-8. PubMed ID: 8386185
[TBL] [Abstract][Full Text] [Related]
2. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
3. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
4. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis.
Adams JS; Gacad MA; Anders A; Endres DB; Sharma OP
Sarcoidosis; 1986 Mar; 3(1):1-6. PubMed ID: 3033783
[TBL] [Abstract][Full Text] [Related]
5. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
[TBL] [Abstract][Full Text] [Related]
6. Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis.
Capolongo G; Xu LH; Accardo M; Sanduzzi A; Stanziola AA; Colao A; Agostini C; Zacchia M; Capasso G; Adams-Huet B; Moe OW; Maalouf NM; Sakhaee K; Hsia CC
J Investig Med; 2016 Jun; 64(5):1025-34. PubMed ID: 27053725
[TBL] [Abstract][Full Text] [Related]
7. Calcium metabolism in sarcoidosis. A follow-up study with respect to parathyroid hormone and vitamin D metabolites.
Alberts C; van den Berg H
Eur J Respir Dis; 1986 Mar; 68(3):186-94. PubMed ID: 3699120
[TBL] [Abstract][Full Text] [Related]
8. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement.
Motoyama K; Inaba M; Emoto M; Morii H; Nishizawa Y
Intern Med; 2002 Jun; 41(6):449-52. PubMed ID: 12135177
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status in urinary calcium stone formation.
Netelenbos JC; Jongen MJ; van der Vijgh WJ; Lips P; van Ginkel FC
Arch Intern Med; 1985 Apr; 145(4):681-4. PubMed ID: 3872644
[TBL] [Abstract][Full Text] [Related]
10. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
Gates S; Shary J; Turner RT; Wallach S; Bell NH
J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
[TBL] [Abstract][Full Text] [Related]
11. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
[TBL] [Abstract][Full Text] [Related]
12. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
13. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
14. Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis.
Insogna KL; Dreyer BE; Mitnick M; Ellison AF; Broadus AE
J Clin Endocrinol Metab; 1988 Jan; 66(1):72-5. PubMed ID: 3335611
[TBL] [Abstract][Full Text] [Related]
15. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
16. [Dysregulation of plasma 1,25(OH)2D in calcium restriction in hypercalciuric children].
Belon C; Dumas R; Tau C; Sabatier R; Bourdeau A; Garabedian M
Arch Fr Pediatr; 1992; 49(6):519-24. PubMed ID: 1449353
[TBL] [Abstract][Full Text] [Related]
17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
18. Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis.
Hamada K; Nagai S; Tsutsumi T; Izumi T
Eur Respir J; 1998 May; 11(5):1015-20. PubMed ID: 9648949
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
